Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices
Market Cap
$591.35 Million
CN¥4.34 Billion CNY
Market Cap Rank
#13184 Global
#3346 in China
Share Price
CN¥18.66
Change (1 day)
-0.85%
52-Week Range
CN¥16.85 - CN¥22.86
All Time High
CN¥49.58
About

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware… Read more

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Total Liabilities

Latest total liabilities as of September 2025: CN¥373.70 Million CNY

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has total liabilities worth CN¥373.70 Million CNY as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Total Liabilities Trend (2011–2024)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Total Liabilities

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their total liabilities.

Liability Composition Analysis (2011–2024)

This chart breaks down Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 15.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.07 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.06 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2024)

The table below shows the annual total liabilities of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥574.40 Million -47.52%
2023-12-31 CN¥1.09 Billion -54.76%
2022-12-31 CN¥2.42 Billion +326.64%
2021-12-31 CN¥567.02 Million +81.87%
2020-12-31 CN¥311.77 Million +1267.39%
2019-12-31 CN¥22.80 Million -7.14%
2018-12-31 CN¥24.55 Million +80.49%
2017-12-31 CN¥13.60 Million -38.35%
2016-12-31 CN¥22.07 Million +18.84%
2015-12-31 CN¥18.57 Million +62.54%
2014-12-31 CN¥11.42 Million +12.05%
2013-12-31 CN¥10.19 Million +215.27%
2012-12-31 CN¥3.23 Million +67.03%
2011-12-31 CN¥1.94 Million --